Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational study

被引:9
作者
Fujii, Hironori [1 ]
Koda, Maaya [2 ]
Sadaka, Shiori [1 ]
Ohata, Koichi [1 ]
Kato-Hayashi, Hiroko [1 ]
Iihara, Hirotoshi [1 ]
Kobayashi, Ryo [1 ]
Ishihara, Takuma [3 ]
Uemura, Shinya [4 ]
Iwashita, Takuji [4 ]
Hayashi, Hideki [2 ]
Sugiyama, Tadashi [2 ]
Shimizu, Masahito [4 ]
Suzuki, Akio [1 ]
机构
[1] Gifu Univ Hosp, Dept Pharm, Yanagido 1-1, Gifu 5011194, Japan
[2] Gifu Pharmaceut Univ, Lab Pharm Practice & Social Sci, Gifu 5011196, Japan
[3] Gifu Univ, Gifu Univ Hosp, Innovat & Clin Res Promot Ctr, Gifu 5011194, Japan
[4] Gifu Univ Hosp, Dept Internal Med 1, Gifu 5011194, Japan
基金
日本学术振兴会;
关键词
Quality of life; Pancreatic cancer; Adverse events related outpatient cancer chemotherapy; Proportional odds logistic regression model; Retrospective observational study; PHASE-III; GEMCITABINE; SURVIVAL; OUTCOMES; JAPAN;
D O I
10.1186/s40780-021-00210-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundCancer chemotherapy usually improves clinical outcomes in patients with advanced pancreatic cancer (APC), but can also cause moderate-to-severe adverse events (AEs). We investigated the relationship between moderate-to-severe AEs and quality of life (QOL) in patients with APC who received outpatient chemotherapy.MethodsWe recruited APC patients who received outpatient chemotherapy in Gifu University Hospital between September 2017 and December 2018. Adverse events related to chemotherapy were assessed by a pharmacist collaborating with a physician using common terminology criteria for AEs (CTCAE) ver 4.0, and QOL of patients was self-assessed by patients using the five-level EuroQol five-dimensional questionnaire (EQ-5D-5L Japanese edition 2). Associations between the EQ-5D-5L utility value and serious AEs were assessed using proportional odds logistic regression.ResultsA total of 59 patients who received 475 chemotherapy cycles were included. The proportional odds logistic regression indicated that grade >= 2 anorexia, pain and peripheral neuropathy were significantly correlated with a decreased EQ-5D-5L utility value. Pharmaceutical intervention for these AEs significantly improved the patients' EQ-5D-5L utility value.ConclusionsAnorexia, pain and peripheral neuropathy were significantly associated with a decrease in QOL. It is assumed that appropriate pharmaceutical intervention with particular emphasis on these AEs can improve the QOL of pancreatic cancer patients receiving outpatient chemotherapy.
引用
收藏
页数:7
相关论文
共 31 条
[1]   Determinants of quality of life among Malaysian cancer patients: a cross-sectional study [J].
Akhtari-Zavare, Mehrnoosh ;
Mohd-Sidik, Sherina ;
Periasamy, Ummavathy ;
Rampal, Lekhraj ;
Fadhilah, Siti Irma ;
Mahmud, Rozi .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2018, 16
[2]  
Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JCO.2010.34.4614, 10.1200/JOP.2011.000397]
[3]   Effects of pain, fatigue, insomnia, and mood disturbance on functional status and quality of life of elderly patients with cancer [J].
Cheng, Karis K. F. ;
Lee, Diana T. F. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (02) :127-137
[4]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825
[5]   Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer [J].
de Mol, Mark ;
Visser, Sabine ;
den Oudsten, Brenda L. ;
Lodder, Paul ;
van Walree, Nico ;
Belderbos, Huub ;
Aerts, Joachim G. .
SUPPORTIVE CARE IN CANCER, 2019, 27 (09) :3563-3572
[6]   Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection [J].
Gilliland, Taylor M. ;
Villafane-Ferriol, Nicole ;
Shah, Kevin P. ;
Shah, Rohan M. ;
Cao, Hop S. Tran ;
Massarweh, Nader N. ;
Silberfein, Eric J. ;
Choi, Eugene A. ;
Hsu, Cary ;
McElhany, Amy L. ;
Barakat, Omar ;
Fisher, William ;
Van Buren, George, II .
NUTRIENTS, 2017, 9 (03)
[7]   Quality of Life in Painful Peripheral Neuropathies: A Systematic Review [J].
Girach, Ayesha ;
Julian, Thomas Henry ;
Varrassi, Giustino ;
Paladini, Antonella ;
Vadalouka, Athina ;
Zis, Panagiotis .
PAIN RESEARCH & MANAGEMENT, 2019, 2019
[8]   Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) [J].
Herdman, M. ;
Gudex, C. ;
Lloyd, A. ;
Janssen, M. F. ;
Kind, P. ;
Parkin, D. ;
Bonsel, G. ;
Badia, X. .
QUALITY OF LIFE RESEARCH, 2011, 20 (10) :1727-1736
[9]   Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy [J].
Hershman, Dawn L. ;
Weimer, Louis H. ;
Wang, Antai ;
Kranwinkel, Grace ;
Brafman, Lois ;
Fuentes, Deborah ;
Awad, Danielle ;
Crew, Katherine D. .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) :767-774
[10]   Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy [J].
Hirose, Chiemi ;
Fujii, Hironori ;
Iihara, Hirotoshi ;
Ishihara, Masashi ;
Nawa-Nishigaki, Minako ;
Kato-Hayashi, Hiroko ;
Ohata, Koichi ;
Sekiya, Kumiko ;
Kitahora, Mika ;
Matsuhashi, Nobuhisa ;
Takahashi, Takao ;
Okuda, Kumiko ;
Naruse, Masayo ;
Ishihara, Takuma ;
Sugiyama, Tadashi ;
Yoshida, Kazuhiro ;
Suzuki, Akio .
SUPPORTIVE CARE IN CANCER, 2020, 28 (12) :5943-5952